Two recent studies have shown that calcium-sensitive receptors (CaSR) in RA patients can mediate NLRP3 inflammasome activation, increase IL-1β levels and exacerbate joint and systemic inflammation (95). The gene discussed is NLRP3; the disease is rheumatoid arthritis.